99mTc-peptide-peptide nucleic acid probes for imaging oncogene mRNAs in tumours
- 1 August 2003
- journal article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 24 (8) , 857-863
- https://doi.org/10.1097/01.mnm.0000084583.29433.df
Abstract
Summary Imaging oncogene mRNA in tumours would provide a powerful tool for the early detection of occult malignant lesions. The goal was to prepare a chimera consisting of a dodecamer antisense peptide nucleic acid (PNA) specific for c-MYC oncogene overexpressed in human breast cancer cells and a chelating moiety that facilitates quantitative radiolabelling with 99mTc and evaluate it for hybridization and tissue distribution in laboratory animals. The pentapeptide chelator-PNA dodecamer specific for c-MYC mRNA was extended from a solid support by 9-fluorenylmethyloxycarbonyl (Fmoc) coupling. Similarly, a chelator-PNA chimera with four central mismatches was also prepared which served as a control. The chimeras were purified, characterized and evaluated for hybridization to c-MYC mRNA by fluorescent, real-time polymerase chain reaction (RT-PCR). The chimeras were labelled with 99mTc and their tissue distribution was examined in athymic nude mice bearing experimental human breast tumours. 99mTc radiolabelling was quantitative and presented a single peak in reversed phase liquid chromatography. Fluorescent real-time polymerase chain reactions using primer and fluorescent probe sets previously calculated for c-MYC mRNA demonstrated inhibition of reverse transcription by the c-MYC specific chimera as compared to that of the control. Tissue distribution studies of antisense and mismatch chimeras at 4 h and 24 h after administration displayed modest accumulation in the liver, and appreciable levels in tumours. These observations suggest that 99mTc-peptide-PNA probes might be useful for imaging gene expression in tumours, and the approach is worthy of further investigation.Keywords
This publication has 17 references indexed in Scilit:
- Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applicationsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Imaging with radiolabeled antisense oligonucleotides for the detection of intracellular messenger RNA and cardiovascular diseaseJournal of Nuclear Cardiology, 1999
- Imaging Thromboembolism with Tc-99m–Labeled Thrombospondin Receptor Analogs TP-1201 and TP-1300Thrombosis Research, 1999
- Progress in Developing PNA as a Gene-Targeted DrugAntisense and Nucleic Acid Drug Development, 1997
- Synthesis and Characterization of a Peptide Nucleic Acid Conjugated to a d-Peptide Analog of Insulin-like Growth Factor 1 for Increased Cellular UptakeBioconjugate Chemistry, 1997
- An assessment of the antisense properties of RNase H-competent and steric-blocking oligomersNucleic Acids Research, 1995
- Peptide nucleic acid (PNA). A DNA mimic with a peptide backboneBioconjugate Chemistry, 1994
- PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rulesNature, 1993
- Peptide nucleic acids and their potential applications in biotechnologyTrends in Biotechnology, 1993
- Fission Mo-99/Tc-99m generators ?A study of their performance and qualityEuropean Journal of Nuclear Medicine and Molecular Imaging, 1980